Details
| Originalsprache | Englisch |
|---|---|
| Veröffentlichungsnummer (amtliches Aktenzeichen) | WO2011095311A1 |
| IPC | A61K47/48,C08G83/00,A61K49/12,A61K49/00 |
| Prioritätsdatum | 2 März 2010 |
| Anmeldedatum | 31 Jan. 2011 |
| Publikationsstatus | Veröffentlicht - 11 Aug. 2011 |
| Extern publiziert | Ja |
Abstract
The present invention relates generally to methods and compositions for targeting of intracellular molecules involved in proliferation and protein synthesis of activated cells using polyanionic multivalent macromolecules. In particular aspect, multiple sulfate groups linked to polyol are specifically targeted to the cytoplasm and nucleus of proliferating and activated cells. The invention further comprises novel polyanionic macromolecular compounds and formulations.
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
Patent Nr.: WO2011095311A1. Aug. 11, 2011.
Publikation: Schutzrecht/Patent › Patent
}
TY - PAT
T1 - Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
AU - Licha, Kai
AU - Schirner, Michael
AU - Welker, Pia
AU - Haag, Rainer
AU - Weinhart, Marie
AU - Paulus, Florian
PY - 2011/8/11
Y1 - 2011/8/11
N2 - The present invention relates generally to methods and compositions for targeting of intracellular molecules involved in proliferation and protein synthesis of activated cells using polyanionic multivalent macromolecules. In particular aspect, multiple sulfate groups linked to polyol are specifically targeted to the cytoplasm and nucleus of proliferating and activated cells. The invention further comprises novel polyanionic macromolecular compounds and formulations.
AB - The present invention relates generally to methods and compositions for targeting of intracellular molecules involved in proliferation and protein synthesis of activated cells using polyanionic multivalent macromolecules. In particular aspect, multiple sulfate groups linked to polyol are specifically targeted to the cytoplasm and nucleus of proliferating and activated cells. The invention further comprises novel polyanionic macromolecular compounds and formulations.
M3 - Patent
M1 - WO2011095311A1
Y2 - 2011/01/31
ER -